arrow
A

Anthony Nardone

european centre for disease prevention & control
H指数:24
被引数:1,857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors associated with SARS-CoV-2 infection among healthcare workers: a European multicentre cohort study, May 2021–April 2024

与医疗保健工作者SARS-CoV-2感染相关的因素:一项欧洲多中心队列研究,2021年5月至2024年4月

2026-08-070
OA
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

2023年秋季XBB.1.5 COVID-19加强针在2024年夏季于欧盟/欧洲经济区内的有效性:一项VEBIS电子健康记录网络研究

2025-11-280
OAAI
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23

2022/23年度在VEBIS-EHR网络中针对秋季加强针的两种COVID-19疫苗有效性估计方法的比较

2025-03-172
OAAI
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
2024-11-251
OA
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023

欧洲卫生保健工作者中SARS-CoV-2感染的发生率和第一个加强新型冠状病毒肺炎疫苗的有效性,VEBIS HCW观察性队列研究,2021年5月-2023年5月

2024-11-192
OAAI
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
2024-10-310
OAAI
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

10月2023年11月,XBB.1.5单价新型冠状病毒肺炎疫苗在欧盟/欧洲经济区国家XBB.1.5主导时期的有效性: vebis-ehr网络研究

2024-04-233
OA
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

≥ 65岁人群新型冠状病毒肺炎住院的相对疫苗有效性: 欧洲VEBIS网络的结果,2021年10月2023年7月

2024-01-041
OAAI
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

2021年10月2022年11月,在六个欧洲国家使用电子健康登记处监测新型冠状病毒肺炎疫苗对新型冠状病毒肺炎住院和死亡的有效性

2023-11-282
OAAI
Evolution of seroprevalence to SARS-CoV-2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross-sectional and longitudinal studies
2023-08-220
OA
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019
2023-02-093
OAAI
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
2022-08-2372
OAAI
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
2022-07-289
OAAI
Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis
2022-06-169
OA
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic

早期流行病学调查: 世界卫生组织统一协议在新型冠状病毒肺炎大流行期间提供了一个标准化和及时的国际调查框架

2021-10-0540
OA